摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3aS,7R,9S,11aS,E)-9-(methoxymethoxy)-2,2,7-trimethyl-3a,4,8,9-tetrahydro-7H-[1,3]dioxolo[4,5-d]oxecin-5(11aH)-one | 185030-61-9

中文名称
——
中文别名
——
英文名称
(3aS,7R,9S,11aS,E)-9-(methoxymethoxy)-2,2,7-trimethyl-3a,4,8,9-tetrahydro-7H-[1,3]dioxolo[4,5-d]oxecin-5(11aH)-one
英文别名
(3aS,7R,9S,10E,11aS)-9-(methoxymethoxy)-2,2,7-trimethyl-3a,4,7,8,9,11a-hexahydro-[1,3]dioxolo[4,5-d]oxecin-5-one
(3aS,7R,9S,11aS,E)-9-(methoxymethoxy)-2,2,7-trimethyl-3a,4,8,9-tetrahydro-7H-[1,3]dioxolo[4,5-d]oxecin-5(11aH)-one化学式
CAS
185030-61-9
化学式
C15H24O6
mdl
——
分子量
300.352
InChiKey
ADESEVAJYFBGFJ-AHTXKAPNSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    21
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.8
  • 拓扑面积:
    63.2
  • 氢给体数:
    0
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Nickel-Catalyzed Coupling Producing (2<i>Z</i>)-2,4-Alkadien-1-ols, Conversion to (<i>E</i>)-3-Alkene-1,2,5-triol Derivatives, and Synthesis of Decarestrictine D
    作者:Yuichi Kobayashi、Shinya Yoshida、Moriteru Asano、Akira Takeuchi、Hukum P. Acharya
    DOI:10.1021/jo0623890
    日期:2007.3.1
    hydroxyl-group-directed epoxidation of 6 followed by palladium-catalyzed reaction with AcOH (Scheme 1) furnished 3-alkene-1,2,5-triol derivatives 8. Since each step proceeded with high stereo- and regioselectivities, the stereochemistry of 8 has been correlated with the olefin geometry of 6. With the above transformation in mind, synthesis of the full carbon skeleton of decarestrictine D (18) could be designed
    3-烯烃-1,2,5-三醇结构不仅是生物学上重要分子的主要框架,还是合成多元醇和糖的新的富含官能团的单元。开发了一种提供这种三醇衍生物8的方法,并成功地将其用于去卡地汀D(18)的合成。首先,研究了未保护的醇2与硼酸酯4的偶联反应,以在室温下在Et 2 O / THF(5:1)中生成具有NiCl 2(dppf)的二烯基醇6。的羟基基团的环氧化定向6,接着用AcOH(方案1)的钯催化反应提供3-烯-1,2,5-三醇衍生物8。由于每个步骤均具有较高的立体选择性和区域选择性,因此8的立体化学与6的烯烃几何结构相关。考虑到上述转变,可以很容易地设计并完成成功的去卡地丁D(18)的全碳骨架的合成。此外,发现具有针对三个羟基的MOM保护基的新的癸二酸19b以比先前报道的更高的产率提供了大环内酯48。
  • A facile chiral pool synthesis of 9-epi-decarestrictine-D, decarestrictine-D and O
    作者:Kuchena Vamshikrishna、Garlapati Srinu、Pabbaraja Srihari
    DOI:10.1016/j.tetasy.2013.12.008
    日期:2014.2
    A facile chiral pool total synthesis of 9-epi-decarestrictine-D, decarestrictine-D and O has been achieved from L-(+)-diethyl tartrate. The strategy utilized is conventional and flexible. Wittig homologation and Grubbs ring closing metathesis are the key reactions employed for the synthesis of the title molecules. (C) 2013 Elsevier Ltd. All rights reserved.
  • Stereoselective Synthesis of Decarestrictine D from a Previously Inaccessible (2<i>Z</i>,4<i>E</i>)-Alkadienyl Alcohol Precursor
    作者:Yuichi Kobayashi、Moriteru Asano、Shinya Yoshida、Akira Takeuchi
    DOI:10.1021/ol050148t
    日期:2005.4.14
    [reaction: see text] The core structure of decarestrictine D was constructed by stereoselective oxygenation of (2Z,4E)-alkadienyl alcohol, which could be synthesized by a nickel-catalyzed coupling reaction between the corresponding cis bromide and trans borate. Efficiency in macrocyclization of the seco acid with Yamaguchi reagent was found to be protective-group-dependent, and the best yield of 40%
    [反应:见正文]通过(2Z,4E)-链二烯基醇的立体选择性氧化来构建去卡地丁D的核心结构,这可以通过相应的顺式溴化物和反式硼酸盐之间的镍催化偶联反应来合成。发现使用Yaguguchi试剂对癸二酸进行大环化的效率取决于保护基,使用具有三MOM保护基的癸二酸可获得40%的最佳收率。
  • Synthesis of Tuckolide, a New Cholesterol Biosynthesis Inhibitor
    作者:Merritt B. Andrus、Tzenge-Lien Shih
    DOI:10.1021/jo961686+
    日期:1996.1.1
    catalytic asymmetric dihydroxylation reaction (AD) of the methoxymethyl (MOM) ether protected diene 2 and a direct Corey-Nicolaou lactonization reaction of seco-acid 1with added silver perchlorate. The selectivity of the dihydroxylation step was found to be highly dependent on the nature of the protecting group adjacent to the diene in 2. The selectivity of the asymmetric dihydroxylation reaction of 2 indicates
    合成了Tuckolide(去甲烯丙胺D),一种从P. corylophilum和多孔菌块菌中分离的10元内酯,可有效抑制胆固醇的生物合成。关键步骤包括甲氧基甲基(MOM)醚保护的二烯2的Sharpless催化不对称二羟基化反应(AD)和癸二酸1加高氯酸银的直接Corey-Nicolaou内酯化反应。发现二羟基化步骤的选择性高度依赖于2中与二烯相邻的保护基团的性质。2的不对称二羟基化反应的选择性表明空间和电子效应均可导致大量不期望的反应。异构体。
查看更多

同类化合物

胰岛素原(cattle),29-[N6-[[2-(甲磺酰)乙氧基]羰基]-L-赖氨酸]-59-[N6-[[2-(甲磺酰)乙氧基]羰基]-L-赖氨酸]-(9CI) 十氢-2,7-苯并二氧杂环癸烷-3,6-二酮 二环<3.3.0>-2-氧杂-5-(2-丙烯基)-1-辛烯 乙烯邻苯二甲酸酯 [(E,1R)-1-[(2R,4Z,7S,8R)-7-溴-8-乙基-3,6,7,8-四氢-2H-氧杂环辛三烯-2-基]己-3-烯-5-炔基]乙酸酯 [(2R,3S,4E,6R,7S)-6,7-二羟基-2-甲基-10-氧代-2,3,6,7,8,9-六氢氧杂环辛三烯-3-基] (E)-丁-2-烯酸酯 6,7-二氢-5aH-氧杂环丁烷并[3,2-d][1,3]苯并二氧戊环 5-氧杂-10-氮杂三环[5.3.1.03,8]十一碳-1(10),2,6,8-四烯 3-氧杂二环[3.3.1]壬-6-烯-9-酮 3,4,5,6-四氢-2,7-苯并二氧杂环癸烷e-1,8-二酮 10-(乙酰氧基)-4,5,6,7-四氢-2H-1-苯并氧杂环辛三烯-2,8(3H)-二酮 1-(2,3,4,5-四氢-1,6-苯并二噁辛英-8-基)丙烷-1-酮 1,2-环己烷二甲酸1-甲基-1,2-乙二基酯 (S)-5-烯丙基-2-氧杂双环[3.3.0]辛-8-烯 (7Z)-2-(3-溴丙-1,2-二烯基)-5-(1-溴丙基)-3,3a,5,6,9,9a-六氢-2H-呋喃并[3,2-b]氧杂环辛三烯 (7E)-4,7-二羟基-10-甲基-3,4,5,6,9,10-六氢氧杂环辛三烯-2-酮 (6Z)-10-甲基-3,4,5,8,9,10-六氢-2H-氧杂环辛三烯-2-酮 (5Z,8S)-3-氯-2-[(E)-戊-2-烯-4-炔基]-8-[(E)-丙-1-烯基]-3,4,7,8-四氢-2H-氧杂环辛三烯 (4Z)-3,6-二氢-2,7-苯并二氧杂环癸烷e-1,8-二酮 (4S,5Z,7S,8S,10R)-4,7,8-三羟基-10-甲基-3,4,7,8,9,10-六氢氧杂环辛三烯-2-酮 (4R,5R,6Z,8S,10R)-4,5,8-三羟基-10-甲基-3,4,5,8,9,10-六氢氧杂环辛三烯-2-酮 (2R,5Z)-8a-[(R)-1-溴丙基]-3a-氯-3,4,7,8-四氢-2a-[(Z)-2-戊烯-4-炔基]-2H-氧杂环辛三烯 1,3,3a,6a-tetrahydro-5-pentyl-4H-cyclopentafuran-4-one trans-1-oxacyclodec-7-ene-2-one 2-epi-herbarumin II (RS)-5-methoxy-2,3,5,6-tetrahydro-8H-benzo[1,4,7]trioxecin β-heptenolactone stagonolide-E fumaric acid butanediyl ester aspinolide A (3R,4R,9S,10R,Z)-4,9-dihydroxy-3-methyl-10-pentyl-3,4,7,8,9,10-hexahydro-2H-oxecin-2-one prelaureatin 8-acetyl-4,4-dimethyl-2,6-dioxo-9-(2-methylpropyl)-2,3,4,5,6,8-hexahydrooxocino[2,3-c]pyrrole 5,6-benzo-2,3-diethoxy-4-oxo-2-hepten-7-olide 3,4,5,6-tetrahydro-oxocin-2-one (Z)-3-butyl-5,6,7,8-tetrahydro-2H-oxocin-2-one presaccharothriolide X 1-{2-[4,5-dihydro-1H-2-benzoxocin-(6Z)-ylidenemethyl]-allyl}-piperidine (R,Z)-8-(methoxymethoxy)-2,2,6,9-tetramethyl-5,6-dihydro-2H-benzo[b]oxocine 5-hydroxy-7R,11-heliannan-10-one 8-methoxy-2,2,6,9-tetramethyl-2H-1-benzoxocin-3(4H)-one 8-methoxy-2,2,6,9-tetramethyl-3,4,5,6-tetrahydro-2H-1-benzoxocin-3-ol (4S,5Z,10R)-4-hydroxy-10-methyl-3,4,7,8,9,10-hexahydro-2H-oxecin-2-one (4R)-9,11-bis(benzyloxy)-4-methyl-4,5,6,7-tetrahydro-1H-benzo[d]-oxecine-2,8-dione ethyl (4Z)-4-methyl-7,8-dihydro-1,3,6-trioxocine-5-carboxylate 4-hydroxy-10-(2-hydroxyethyl)-1,2-dihydro-4,12a-methanooxocino[4,5-b][1,4]benzodioxin-5-one 4-hydroxy-9-(2-hydroxyethyl)-1,2-dihydro-4,12a-methanooxocino[4,5-b][1,4]benzodioxin-5-one (7R,9R,5E)-7-hydroxy-9-propylnon-5-en-9-olide (6S,7R,9R)-6,7-dihydroxy-9-propylnon-4-eno-9-lactone 7-[2-(3,5-Dichloro-N-oxo-pyridin-4-yl)-1-oxoethyl]-10-methoxy-2,3,4,5-tetrahydro-1,6-benzodioxocine